Christopher V. Lutman

543 total citations
9 papers, 409 citations indexed

About

Christopher V. Lutman is a scholar working on Obstetrics and Gynecology, Oncology and Reproductive Medicine. According to data from OpenAlex, Christopher V. Lutman has authored 9 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Obstetrics and Gynecology, 3 papers in Oncology and 3 papers in Reproductive Medicine. Recurrent topics in Christopher V. Lutman's work include Endometrial and Cervical Cancer Treatments (4 papers), Estrogen and related hormone effects (2 papers) and Uterine Myomas and Treatments (2 papers). Christopher V. Lutman is often cited by papers focused on Endometrial and Cervical Cancer Treatments (4 papers), Estrogen and related hormone effects (2 papers) and Uterine Myomas and Treatments (2 papers). Christopher V. Lutman collaborates with scholars based in United States and Canada. Christopher V. Lutman's co-authors include John T. Soper, Andrew Berchuck, Brian Calingaert, Janiel M. Cragun, Daniel L. Clarke‐Pearson, Laura J. Havrilesky, Angeles Alvarez Secord, Donn C. Young, Harrison G. Weed and Albert J. Bonebrake and has published in prestigious journals such as The Laryngoscope, Gynecologic Oncology and Modern Pathology.

In The Last Decade

Christopher V. Lutman

9 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher V. Lutman United States 7 248 194 68 58 54 9 409
Varol Gülseren Türkiye 9 152 0.6× 112 0.6× 37 0.5× 15 0.3× 3 0.1× 51 272
Mert Göl Türkiye 11 173 0.7× 108 0.6× 42 0.6× 21 0.4× 1 0.0× 23 382
Robert Armbrust Germany 9 107 0.4× 75 0.4× 22 0.3× 11 0.2× 3 0.1× 31 311
Srividhya Sankaran United Kingdom 10 287 1.2× 96 0.5× 42 0.6× 23 0.4× 2 0.0× 23 454
Teresa M. MacDonald Australia 14 530 2.1× 10 0.1× 26 0.4× 56 1.0× 3 0.1× 40 666
Riccardo Gismondi Italy 6 249 1.0× 115 0.6× 45 0.7× 55 0.9× 7 917
Aslı Somunkiran Türkiye 11 192 0.8× 158 0.8× 12 0.2× 13 0.2× 1 0.0× 19 473
Özlem Seçilmiş Kerimoğlu Türkiye 12 120 0.5× 191 1.0× 45 0.7× 54 0.9× 1 0.0× 46 426
Leslie Touger United States 3 185 0.7× 77 0.4× 28 0.4× 34 0.6× 4 317
Péter Török Hungary 12 261 1.1× 151 0.8× 8 0.1× 34 0.6× 1 0.0× 40 421

Countries citing papers authored by Christopher V. Lutman

Since Specialization
Citations

This map shows the geographic impact of Christopher V. Lutman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher V. Lutman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher V. Lutman more than expected).

Fields of papers citing papers by Christopher V. Lutman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher V. Lutman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher V. Lutman. The network helps show where Christopher V. Lutman may publish in the future.

Co-authorship network of co-authors of Christopher V. Lutman

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher V. Lutman. A scholar is included among the top collaborators of Christopher V. Lutman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher V. Lutman. Christopher V. Lutman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Whitcomb, Bradford P., Christopher V. Lutman, Michael L. Pearl, et al.. (2020). Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement. Gynecologic Oncology. 157(2). 307–311. 16 indexed citations
2.
Whitcomb, Bradford P., Christopher V. Lutman, Michael L. Pearl, et al.. (2020). Use of Cannabinoids in Cancer Patients: A Society of Gynecologic Oncology (SGO) Clinical Practice Statement. Obstetrical & Gynecological Survey. 75(7). 408–409. 1 indexed citations
3.
Rimel, B.J., William M. Burke, Robert V. Higgins, et al.. (2015). Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice. Gynecologic Oncology. 137(2). 280–284. 22 indexed citations
4.
Covens, Allan, Virginia L. Filiaci, Deborah J. Gersell, et al.. (2010). Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study. Gynecologic Oncology. 120(2). 185–188. 51 indexed citations
5.
Soper, John T., et al.. (2008). Cutaneous malignant melanoma metastatic to a uterine leiomyoma: a case report.. PubMed. 53(9). 697–9. 4 indexed citations
6.
Li, Cuizhen, Victor Zota, Bruce A. Woda, et al.. (2007). Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Modern Pathology. 20(12). 1263–1268. 61 indexed citations
7.
Lutman, Christopher V., Laura J. Havrilesky, Janiel M. Cragun, et al.. (2006). Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecologic Oncology. 102(1). 92–97. 167 indexed citations
8.
Lutman, Christopher V., Laura J. Havrilesky, Janiel M. Cragun, et al.. (2006). Pelvic Lymph Node Count is an Important Prognostic Variable for FIGO Stage I and II Endometrial Carcinoma With High-Risk Histology. Obstetrical & Gynecological Survey. 61(10). 642–644. 13 indexed citations
9.
Weed, Harrison G., et al.. (1995). Preoperative identification of patients at risk for delirium after major head and neck cancer surgery. The Laryngoscope. 105(10). 1066–1068. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varol Gülseren Breakdown of academic impact, for papers by Mert Göl Breakdown of academic impact, for papers by Robert Armbrust Breakdown of academic impact, for papers by Srividhya Sankaran Breakdown of academic impact, for papers by Teresa M. MacDonald Breakdown of academic impact, for papers by Riccardo Gismondi Breakdown of academic impact, for papers by Aslı Somunkiran Breakdown of academic impact, for papers by Özlem Seçilmiş Kerimoğlu Breakdown of academic impact, for papers by Leslie Touger Breakdown of academic impact, for papers by Péter Török
Rankless by CCL
2026